Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Moodys
Boehringer Ingelheim
Mallinckrodt
Baxter
McKesson
Express Scripts

Last Updated: October 23, 2019

DrugPatentWatch Database Preview

Venlafaxine hydrochloride - Generic Drug Details

See Plans and Pricing

« Back to Dashboard

What are the generic drug sources for venlafaxine hydrochloride and what is the scope of freedom to operate?

Venlafaxine hydrochloride is the generic ingredient in three branded drugs marketed by Wyeth Pharms, Anchen Pharms, Annora Pharma, Aurobindo Pharma Ltd, Dr Reddys Labs Ltd, Intellipharmaceutics, Macleods Pharms Ltd, Mylan, Orchid Hlthcare, Teva, Torrent Pharms Llc, Valeant Pharms North, Wockhardt, Zydus Pharms Usa Inc, Cadila Pharms Ltd, Nostrum Labs Inc, Osmotica Pharm, Sun Pharm, Wyeth Pharms Inc, Alembic Pharms Ltd, Amneal Pharms, Aurobindo Pharma, Fosun Pharma, Heritage Pharms Inc, Pliva Hrvatska Doo, Prinston Inc, Sun Pharm Inds Inc, Yaopharma Co Ltd, and Zydus Pharms Usa, and is included in thirty-three NDAs. Additional information is available in the individual branded drug profile pages.

There are seventy-one drug master file entries for venlafaxine hydrochloride. Sixty suppliers are listed for this compound. There are two tentative approvals for this compound.

Recent Clinical Trials for venlafaxine hydrochloride

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Noam SoreniPhase 3
Guangzhou General Hospital of Guangzhou Military CommandN/A
Wake Forest University Health SciencesPhase 4

See all venlafaxine hydrochloride clinical trials

Recent Litigation for venlafaxine hydrochloride

Identify potential future generic entrants

District Court Litigation
Case NameDate
WYETH v. ORGENUS PHARMA INC.2009-07-02
Wyeth v. Cadila Healthcare Limited2009-04-09
Sunovion Pharmaceuticals Inc. v. Barr Laboratories, Inc.2008-07-30

See all venlafaxine hydrochloride litigation

Generic filers with tentative approvals for VENLAFAXINE HYDROCHLORIDE
Applicant Application No. Strength Dosage Form
  Start Trial  Start Trial150MGCAPSULE, EXTENDED RELEASE; ORAL
  Start Trial  Start Trial75MGCAPSULE, EXTENDED RELEASE; ORAL
  Start Trial  Start Trial37.5MGCAPSULE, EXTENDED RELEASE; ORAL

The 'tentative' approval signifies that the product meets all FDA standards for marketing, and, but for the patents / regulatory protections, it would approved.

Pharmacology for venlafaxine hydrochloride
Medical Subject Heading (MeSH) Categories for venlafaxine hydrochloride
Synonyms for venlafaxine hydrochloride
(+-)-1-(alpha-((Dimethylamino)methyl)-p-methoxybenzyl)cyclohexanol hydrochloride
(+/-)-1-(alpha-((Dimethylamino)methyl)-p-methoxybenzyl)cyclohexanol hydrochloride
(+/-)-1-[2-(dimethylamino)-1-(4-methoxyphenyl)ethyl]cyclohexanol hydrochloride
(R/S)-1-[2-(dimethylamino)-1-(4-methoxyphenyl)ethyl] cyclohexanol hydrochloride
(RS)-1-(2-Dimethylamino-1-(4-methoxyphenyl)ethyl)cyclohexanol hydrochloride
(RS)-1-[2-(DIMETHYLAMINO)-1-(4-METHOXYPHENYL)ETHYL]CYCLOHEXANOL HYDROCHLORIDE
1-(2-(dimethylamino)-1-(4-methoxyphenyl)ethyl)cyclohexan-1-ol hydrochloride
1-(2-(Dimethylamino)-1-(4-methoxyphenyl)ethyl)cyclohexanol hydrochloride
1-[2-(dimethylamino)-1-(4-methoxyphenyl)ethyl]-1-cyclohexanol hydrochloride
1-[2-(dimethylamino)-1-(4-methoxyphenyl)ethyl]cyclohexan-1-ol hydrochloride
1-[2-(dimethylamino)-1-(4-methoxyphenyl)ethyl]cyclohexan-1-ol;hydrochloride
1-[2-(dimethylamino)-1-(4-methoxyphenyl)ethyl]cyclohexanol hydrochloride
1-[2-(dimethylamino)-1-(4-methoxyphenyl)ethyl]cyclohexanol, hcl
1-[2-Dimethylamino-1-(4-methoxy-phenyl)-ethyl]-cyclohexanol hydrochloride
1-[2-Dimethylamino-1-(4-methoxyphenyl)ethyl]cyclohexanol -HCl
93413-69-5 (Parent)
99300-78-4
A845995
AB0012466
AB2000111
AC-1696
AC1L1Y1S
akos 92111
AKOS000280874
AKOS016340594
AN-14687
ANW-42650
API0004582
BC208275
BCP21401
BG0478
BVF-012
C17H27NO2.HCl
CAS-99300-78-4
CCG-100979
CCG-213270
CHEBI:9944
CHEMBL1201066
CPD000469154
CS-2130
CTK5I0329
Cyclohexanol, 1-(2-(dimethylamino)-1-(4-methoxyphenyl)ethyl)-, hydrochloride
d,l-venlafaxine, hydrochloride
D00821
Dobupal
DSSTox_CID_27397
DSSTox_GSID_47397
DSSTox_RID_82318
DTXSID8047397
Efectin
Efexor
Efexor XL
Effexor
Effexor (TN)
Effexor LP
Effexor XL
Effexor XR
Effexor;Effexor XR;Efexor
FT-0642395
H13V695
HSDB 6699
HY-B0196A
I01-1036
J10231
KB-08072
KM3503
KS-00000WXA
KS-5049
LP00449
LS-57096
MCULE-5156532617
MFCD03658865
MLS001401454
MolPort-003-987-504
NC00229
NCGC00256703-01
NCGC00261134-01
NSC-745751
NSC745751
PF-00345408
PW-4112
QYRYFNHXARDNFZ-UHFFFAOYSA-N
s1441
SAM001246572
SC-23352
SCHEMBL41936
SMR000469154
SW197609-3
TL8006063
Tox21_302508
Tox21_500449
TR-030420
Trevilor
Vandral
Venlafaxin HCL
Venlafaxine (hydrochloride)
Venlafaxine EA
Venlafaxine for system suitability, European Pharmacopoeia (EP) Reference Standard
VENLAFAXINE HCl
Venlafaxine Hydorchloride
venlafaxine hydro chloride
Venlafaxine hydrochloride (JAN/USAN)
Venlafaxine hydrochloride [USAN:USP]
Venlafaxine hydrochloride [USAN]
Venlafaxine Hydrochloride 1.0 mg/ml in Methanol (as free base)
Venlafaxine hydrochloride solution, 1.0 mg/mL in methanol (as free base), ampule of 1 mL, certified reference material
Venlafaxine hydrochloride, >=98% (HPLC), powder
Venlafaxine hydrochloride, European Pharmacopoeia (EP) Reference Standard
Venlafaxine Hydrochloride, Pharmaceutical Secondary Standard; Certified Reference Material
Venlafaxine hydrochloride, United States Pharmacopeia (USP) Reference Standard
Venlafaxine XR
Venlafaxine, HCl
Venlafaxinehydrochloride
Venlift; Vexor; WY 45030
Wy 45030
Wy-45,030
Wy-45,030 Hcl; 9490-3
Wy-45030

US Patents and Regulatory Information for venlafaxine hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Valeant Pharms North VENLAFAXINE HYDROCHLORIDE venlafaxine hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 090071-002 Apr 15, 2011 AB RX No No   Start Trial   Start Trial   Start Trial
Macleods Pharms Ltd VENLAFAXINE HYDROCHLORIDE venlafaxine hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 204889-003 Oct 5, 2017 AB RX No No   Start Trial   Start Trial   Start Trial
Fosun Pharma VENLAFAXINE HYDROCHLORIDE venlafaxine hydrochloride TABLET;ORAL 077515-002 Jun 13, 2008 DISCN No No   Start Trial   Start Trial   Start Trial
Mylan VENLAFAXINE HYDROCHLORIDE venlafaxine hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 078789-003 Jun 1, 2011 DISCN No No   Start Trial   Start Trial   Start Trial
Anchen Pharms VENLAFAXINE HYDROCHLORIDE venlafaxine hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 078087-003 Mar 16, 2012 DISCN No No   Start Trial   Start Trial   Start Trial
Sun Pharm Inds Inc VENLAFAXINE HYDROCHLORIDE venlafaxine hydrochloride TABLET;ORAL 078627-005 Jun 13, 2008 AB RX No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for venlafaxine hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Wyeth Pharms EFFEXOR XR venlafaxine hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 020699-003 Oct 20, 1997   Start Trial   Start Trial
Osmotica Pharm VENLAFAXINE HYDROCHLORIDE venlafaxine hydrochloride TABLET, EXTENDED RELEASE;ORAL 022104-004 May 20, 2008   Start Trial   Start Trial
Osmotica Pharm VENLAFAXINE HYDROCHLORIDE venlafaxine hydrochloride TABLET, EXTENDED RELEASE;ORAL 022104-002 May 20, 2008   Start Trial   Start Trial
Wyeth Pharms Inc EFFEXOR venlafaxine hydrochloride TABLET;ORAL 020151-004 Dec 28, 1993   Start Trial   Start Trial
Wyeth Pharms EFFEXOR XR venlafaxine hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 020699-003 Oct 20, 1997   Start Trial   Start Trial
Wyeth Pharms EFFEXOR XR venlafaxine hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 020699-004 Oct 20, 1997   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Moodys
Merck
Harvard Business School
Colorcon
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.